Wells Fargo
IBBQ icon

Wells Fargo’s Invesco NASDAQ Biotechnology ETF IBBQ Stock Holding History

Wells Fargo’s Portfolio IBBQ Stock Details IBBQ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.78K Hold
85
– – ﹤0.01% 6322
2026
Q1 		$2.46K Buy
+85
New +$2.47K ﹤0.01% 6226

Other funds holding IBBQ

Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
WG
WMS Group Folsom, Louisiana $77.5M AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
IAA
Independent Advisor Alliance Charlotte, North Carolina $4.27B AUM 45.92% 1-Year Est. Return
KAM
Knightsbridge Asset Management Newport Beach, California $762M AUM 59.13% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $8.83B AUM 38.5% 1-Year Est. Return
CFA
Churchill Financial Advisors Louisville, Kentucky $519M AUM
BCI
Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return
CA
Clearstead Advisors Cleveland, Ohio $10.6B AUM 24.87% 1-Year Est. Return

Wells Fargo's IBBQ Position: Q2 2026 in Review

Wells Fargo held its Invesco NASDAQ Biotechnology ETF (IBBQ) position steady in Q2 2026 at 85 shares worth $2.78K. The position accounts for ﹤0.01% of the portfolio, ranked #6322.

Wells Fargo first reported a position in IBBQ in Q1 2026 and has held it in 2 quarters since. 35 funds tracked by Wall St. Rank hold IBBQ as of Q2 2026.

  • Wells Fargo held 85 shares of Invesco NASDAQ Biotechnology ETF worth $2.78K as of Q2 2026.
  • Wells Fargo left its Invesco NASDAQ Biotechnology ETF share count unchanged in Q2 2026.
  • Invesco NASDAQ Biotechnology ETF made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #6322 holding.
  • Wells Fargo first reported a position in Invesco NASDAQ Biotechnology ETF in Q1 2026 and has held it in 2 quarters since.
  • 35 funds tracked by Wall St. Rank held Invesco NASDAQ Biotechnology ETF as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.